SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
xixixi
Lv1
38 积分
2024-08-08 加入
最近求助
最近应助
互助留言
Dissecting liver inflammation ecosystem identifies annexin A1 as a pro-resolving target for liver failure
2天前
已完结
Peginterferon a-2b promoted HBsAg loss in nucleos(t)ide analogue-treated patients: a large-scale real-world study
4个月前
已关闭
Stopping nucleos(t)ide analogues in chronic hepatitis B using HBsAg thresholds: A meta analysis and meta-regression
4个月前
已完结
OS-030 efficacy and safety of xal⁃ nesiran with and without an immunomodulator in virologically sup⁃ pressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label plat⁃ form study (PIRANGA)
4个月前
已完结
Down-regulated cylindromatosis enhances NF-κB activation and aggravates inflammation in HBV-ACLF patients
10个月前
已完结
ETS2 alleviates acute‐on‐chronic liver failure by suppressing excessive inflammation
11个月前
已完结
SPARC inhibition accelerates NAFLD‐associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism
11个月前
已完结
TUBB4B is a novel therapeutic target in non‐alcoholic fatty liver disease‐associated hepatocellular carcinoma
11个月前
已完结
Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway
11个月前
已完结
Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target
11个月前
已完结
没有进行任何应助
感谢
2天前
感谢
4个月前
感谢
4个月前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论